Register Now
Why register?
Login
 The leading web portal for pharmacy resources, news, education and careers September 19, 2017
Pharmacy Choice - Pharmaceutical News - Akebia Therapeutics, Inc. Files SEC Form 10-K, Annual Report [Section 13 And 15(D), Not S-k Item 405] (Mar. 6, 2017) - September 19, 2017

Pharmacy News Article

 3/20/17 - Akebia Therapeutics, Inc. Files SEC Form 10-K, Annual Report [Section 13 And 15(D), Not S-k Item 405] (Mar. 6, 2017)

By a News Reporter-Staff News Editor at Pharma Business Week According to news reporting originating from Washington, D.C., by NewsRx journalists, a U.S. Securities and Exchange Commission (SEC) filing by Akebia Therapeutics, Inc. (Form 10-K) was posted on March 6, 2017.

The SIC code for this company is 2834, Pharmaceutical Preparations.

The SEC file number is 0001564590-17-003466.

The contact information for this company is 245 FIRST STREET, SUITE 1100, CAMBRIDGE MA 02142, 617-871-2098.

Our editors provided additional information about Form 10-K: This is the annual report that most reporting companies file with the Commission. It provides a comprehensive overview of the registrant's business. The report must be filed within 90 days after the end of the company's fiscal year.

A U.S. Securities and Exchange Commission filing is a formal document or financial statement submitted to the SEC by publicly-traded companies.

For additional information on this SEC filing see: http://www.sec.gov/Archives/edgar/data/1517022/0001564590-17-003466-index.html.

Keywords for this news article include: Pharmaceutical Companies, SEC Filing, Akebia Therapeutics Inc..

Our reports deliver fact-based news of research and discoveries from around the world. Copyright 2017, NewsRx LLC



(c) 2017 NewsRx LLC

Pharmacy News Index
  Drug Delivery Systems
  Drugstores
  FDA Final Approvals
  Front Page Healthcare News
  Generic Drugs
  Hospital Industry
  Internet Pharmacy
  IT in Healthcare
  Medicare & Medicaid
  Over-the-Counter Drugs
  Pharm Industry Trends and Policy
  Pharmaceutical Development
  Pharmaceutical Industry

LIVE ONLINE CE

Last Chance
Sep 20: What's New? New Treatments for Type 2 Diabetes
Last Chance
Sep 21: Biosimilar Drugs: Legal, Regulatory & Safety Considerations
Sep 22: Influenza 2017-2018: An Update on Prevention and Treatment
Sep 24: Using Effective Communication to Reduce Medication Errors
Sep 25: Management of Major Depressive Disorders
Click for entire Webinar Calendar

Special Announcement

Free Membership
Enjoy Drug Search, industry newsletters and more...

Nursing Jobs
Are you a nurse looking for a job?

Check out the Nursing Job Source.

Your number one choice for nursing jobs.



Websites » RxCareerCenter.comRxSchool.comClubStaffing.comNursingJobSource.comRN.com
Copyright © 2017 Pharmacy Choice - All rights reserved.
Terms and Conditions | Privacy Statement
888-682-4415